Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
akinetic mute
blood transfusion
bone marrow infarction
bone marrow necrosis
brain purpura
CAT scan, negative
cerebral embolism
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, multiple
cerebrovascular accident, three territory involvement
chondrosarcoma
Clinical Pathologic Conference(C.P.C.)
coma
complications
disability, neurological
dyspnea
embolism, fat
encephalitis
encephalopathy
ferritinemia
fever
fracture, long bone
fracture, pathologic
geographic location
hemoglobin abnormality, neurologic complications of
hip arthroplasty
hip fracture
hyponatremia
infection
intracerebral hemorrhage, multiple
iron, serum, elevated
lactic dehydrogenase(LDH)
lacunar infarction
lesions too numerous to count
lethargy
leukocytosis
level of consciousness, decreased
linear lesion
long bone lesion
meningeal enhancement
mental status, abnormal
microhemorrhage, intracerebral
mortality
MRI
MRI pattern
MRI, abnormal
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, gradient-echo
MRI, negative
MRI, punctate pattern
MRI, starfield pattern
MRI, susceptibility weighted
neurologic complications of, surgery
neurologic complications of, systemic disease
osteolytic lesion, causes of
pain, abdominal
pain, total body
petechiae
prognosis
rash
respiratory failure
review article
rickettsial organism
Rocky Mountain spotted fever
sarcoma
sickle cell crisis
sickle cell disease
skin, lesions in neurologic disorders
somnolence
systemic illness
tachycardia
Three territory sign
thrombocytopenia
tick bite
treatment of neurologic disorder
viral infection
Showing articles 100 to 150 of 770 << Previous Next >>

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Glial Fibrillary Acidic Protein Immunoglobulin G as Biomarker of Autoimmune Astrocytopathy: Analysis of 102 Patients
Ann Neurol 81:298-309, Flanagan, E.P.,et al, 2017

Pseudoradial Nerve Palsy Caused by Acute Ischemic Stroke
J Invest Med Case Report doi:10.1177/2324709616658310, Tahir, H.,et al, 2016

Herpes Simplex Encephalitis in an Immunocompromised Adult with Novel MRI and Pathology Findings
Clin Neuroradiol DOI: 10.1007/s00062-016-0536-x, Modak, J.,et al, 2016

Central Canal Enhancement and the Trident Sign in Spinal Cord Sarcoidosis
Neurol 87:743-744, Zalewski, N.L.,et al, 2016

The Contemporary Spectrum of Multiple Sclerosis Misdiagnosis
Neurol 87:1393-1399, Solomon, A.J.,et al, 2016

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

Emerging Risk Factors for Recurrent Vascular Events in Patients with Embolic Stroke of Unertermined Source
Stroke 47:2714-2721, Ueno, Y.,et al, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Zika Virus Associated with Meningoencephalitis
NEJM 374:1595-1596, Carteau, G.,et al, 2016

Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016

Longitudinally Extensive Spinal Cord Lesions Disclosing Occult Systemic Sarcoidosis
JAMA Neurol 73:600-601, Sechi, E.,et al, 2016

Neurologic Signs and Symptoms Frequently Manifest in Acute HIV Infection
Neurol 87:148-154, Hellmuth, J.,et al, 2016

A 64-year-old Man with Progressive Paraspinal Muscle Weakness
Neurol 86:e4-e9, Schneider, R.,et al, 2016

Punctate Pattern, A promising imaging marker for the diagnosis of natalizumab-associated PML
Neurol 86:1516-1523, Hodel, J.,et al, 2016

A Young Woman with Blurred Vision and Distal Paresthesias
JAMA Neurol 72:1519-1523, Kung, N.H.,et al, 2015

A 48-year-old Man with Walking Difficulty
Neurol 85:e165-e169, Kalladka, D.,et al, 2015

Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015

Effect of Clopidogrel with Aspirin on Functional Outcome in TIA or Minor Stroke
Neurol 85:573-579,562, Wang, X.,et al, 2015

Oral Versus Intravenous High-Dose Methylprednisolone for Treatment of Relapses in Patients with Multiple Sclerosis (COPOUSEP):A Randomised, Controlled, Double-Blind,Non-Inferiority Trial
Lancet 386:974-981, LePage,E.,et al, 2015

Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments
Stroke 46:2987-2990, Kamal, N.,et al, 2015

A 73-year-old Man with Diplopia and Ataxia
Neurol 85:e96-e100, Gupta, H.V.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

SLIPPERS: Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids
Neurol 84: Suppl P5.118, Armand, C.,et al, 2015

Marburgs Variant of Multiple Sclerosis with Extensive Brain Lesions
Int J Neurol Neurother doi:10.23937/2378-3001/2/1/1027, Ludwig, A.,et al, 2015

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Subacute Sclerosing Panencephalitis
Adams & Victors Principles of Neurology, Chp 33, pg 766, Ropper, A.H.,et al, 2014

Dynamic MR Imaging Patterns of Cerebral Fat Embolism: A Systematic Review with Illustrative Cases
AJNR 35:1052-1057, Kuo, K.H.,et al, 2014

IgG4-Related Hypertrophic Pachymeningitis
JAMA Neurol 71:785-793, Lu, L.X.,et al, 2014

Amyloid-Beta Related Angiitis of the Central Nervous System: Case Report and Topic Review
Front Neurol 5:1-4, Nouh, A.,et al, 2014

Small Strokes Causing Severe Vertigo
Neurol 83:169-173, Tehrani, A.S.S.,et al, 2014

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

CD49d Antisense Drug ATL1102 Reduces Disease Activity in Patients with Relapsing-Remitting MS
Neurol 83:1780-1788, Limmroth, V.,et al, 2014

Enhancing Brain Lesions after Endovascular Treatment of Aneurysms
AJNR 35:1954-1958, Cruz, J.P.,et al, 2014

Sensitivity and Specificity of the Hyperdence Artery Sign for Arterial Obstruction in Acute Ischemic Stroke
Stroke 46:102-107, Mair, G.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Evaluation of Cryptogenic Stroke with Advanced Diagnostic Techniques
Stroke 45:1186-1194, Bang, O.Y.,et al, 2014

DWI Reversal is Associated with Small Infarct Volume in Patient with TIA and Minor Stroke
AJNR 35:660-666, Asdaghi, N.,et al, 2014

Remote or Extraischemic Intracerebral Hemorrhage - An Uncommon Complication of Stroke Thrombolysis
Stroke 45:1657-1663, Mazya, M.V.,et al, 2014

Progressive Cerebellar Ataxia and New-Onset Diabetes
Lancet 383:186, Kong, M.,et al, 2014

Hemiballism in a Patient with Parietal Lobe Infarction
Neurol 80:e22, Wu, M.C.,et al, 2013

Febrile Infection-Related Epilepsy Syndrome: A Study of 12 Patients
Seizure 22:553-559, Caraballo, R.H.,et al, 2013

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Computed Tomography Angiography in Hyperacute Ischemic Stroke
Stroke 44:1480-1488, Mortimer, A.,et al, 2013

Characterising Aggressive Multiple Sclerosis
JNNP doi:10.1136 1-7, Menon, S.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013



Showing articles 100 to 150 of 770 << Previous Next >>